{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:49:18Z","timestamp":1789469358031,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cgh.2021.06.047","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:27:42Z","timestamp":1625142462000},"page":"1480-1487.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population"],"prefix":"10.1016","volume":"20","author":[{"given":"Simon C.","family":"Mathews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Izmailyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Miguel","family":"Yamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances L.","family":"Revere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.06.047_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib2","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","article-title":"Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/j.gastro.2009.01.015","article-title":"Burden of digestive diseases in the United States part II: lower gastrointestinal diseases","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","article-title":"Burden of gastrointestinal disease in the United States: 2012 update","volume":"143","author":"Peery","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/ajg.2013.199","article-title":"Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States","volume":"108","author":"Myer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.06.047_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2015.08.045","article-title":"Burden of gastrointestinal, liver, and pancreatic diseases in the United States","volume":"149","author":"Peery","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib8","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","article-title":"The burden of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.06.047_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izz104","article-title":"The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation","volume":"26","author":"Park","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2021.06.047_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cgh.2019.07.022","article-title":"Lifetime economic burden of Crohn\u2019s disease and ulcerative colitis by age at diagnosis","volume":"18","author":"Lichtenstein","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.06.047_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archinte.163.8.929","article-title":"The economic consequences of irritable bowel syndrome: a US employer perspective","volume":"163","author":"Leong","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2021.06.047_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.18553\/jmcp.2016.16138","article-title":"Economic burden of irritable bowel syndrome with diarrhea: retrospective analysis of a US commercially insured population","volume":"23","author":"Buono","year":"2017","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"key":"10.1016\/j.cgh.2021.06.047_bib13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.18553\/jmcp.2014.20.4.382","article-title":"Economic burden of irritable\u00a0bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population","volume":"20","author":"Doshi","year":"2014","journal-title":"Journal of Managed Care Pharmacy"},{"key":"10.1016\/j.cgh.2021.06.047_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.18553\/jmcp.2011.17.7.531","article-title":"All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective","volume":"17","author":"McAdam-Marx","year":"2011","journal-title":"Journal of Managed Care Pharmacy"},{"key":"10.1016\/j.cgh.2021.06.047_bib15","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/hep.30094","article-title":"Healthcare cost and utilization in nonalcoholic fatty liver disease: real-world data from a large US claims database","volume":"68","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.06.047_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3111\/13696990903526676","article-title":"The economics of upper gastrointestinal bleeding in a US managed-care setting: a retrospective, claims-based analysis","volume":"13","author":"Cryer","year":"2010","journal-title":"Journal of Medical Economics"},{"key":"10.1016\/j.cgh.2021.06.047_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3111\/13696998.2013.860375","article-title":"Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population","volume":"17","author":"Cai","year":"2014","journal-title":"Journal of Medical Economics"},{"key":"10.1016\/j.cgh.2021.06.047_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1185\/030079905X38240","article-title":"The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database","volume":"21","author":"Joish","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cgh.2021.06.047_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2036.2007.03428.x","article-title":"Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States","volume":"26","author":"Brook","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.06.047_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.14309\/ajg.0000000000000143","article-title":"Burden and cost of outpatient hemorrhoids in the United States employer-insured population, 2014","volume":"114","author":"Yang","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.06.047_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MPA.0b013e3180cac24b","article-title":"Direct medical costs of acute pancreatitis hospitalizations in the United States","volume":"35","author":"Fagenholz","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.cgh.2021.06.047_bib22","first-page":"e118","article-title":"Direct costs of diverticulitis in a US managed care population","volume":"4","author":"Yen","year":"2012","journal-title":"Am J Pharm Benefits"},{"key":"10.1016\/j.cgh.2021.06.047_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders: results of Rome Foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2019.12.014","article-title":"Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms","volume":"158","author":"Delshad","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.06.047_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/000313481007600720","article-title":"Small bowel obstruction: outcome and cost implications of admitting service","volume":"76","author":"Oyasiji","year":"2010","journal-title":"American Surgeon"},{"key":"10.1016\/j.cgh.2021.06.047_bib26","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1016\/j.jve.2020.06.001","article-title":"Price of a hepatitis C cure: cost of production and current prices for direct-acting antivirals in 50 countries","volume":"6","author":"Barber","year":"2020","journal-title":"Journal of Virus Eradication"},{"key":"10.1016\/j.cgh.2021.06.047_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep4.1524","article-title":"Health care use and costs\u00a0among patients with nonalcoholic steatohepatitis with advanced fibrosis using the fibrosis-4 score","volume":"4","author":"Gordon","year":"2020","journal-title":"Hepatology Communications"},{"key":"10.1016\/j.cgh.2021.06.047_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the US in 2017","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2021.06.047_bib29","first-page":"353","article-title":"Health resource utilization and direct costs associated with angina for patients with coronary artery disease in a US managed care setting","volume":"4","author":"Kempf","year":"2011","journal-title":"American Health & Drug Benefits"},{"issue":"Suppl","key":"10.1016\/j.cgh.2021.06.047_bib30","first-page":"S163","article-title":"All-cause costs increase exponentially with increased chronic kidney disease stage","volume":"23","author":"Golestaneh","year":"2017","journal-title":"American Journal of Managed Care"},{"key":"10.1016\/j.cgh.2021.06.047_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3899\/jrheum.191187","article-title":"Healthcare utilization and costs of systemic lupus erythematosus by disease severity in the United States","volume":"48","author":"Murimi-Worstell","year":"2021","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cgh.2021.06.047_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/13696998.2020.1813144","article-title":"Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance: the perspective of private and public payers","volume":"23","author":"Shah","year":"2020","journal-title":"Journal of Medical Economics"},{"key":"10.1016\/j.cgh.2021.06.047_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.18553\/jmcp.2010.16.9.703","article-title":"All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States","volume":"16","author":"Asche","year":"2010","journal-title":"Journal of Managed Care Pharmacy"},{"key":"10.1016\/j.cgh.2021.06.047_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/cer-2018-0140","article-title":"Medicaid spending burden among beneficiaries with treatment-resistant depression","volume":"8","author":"Pilon","year":"2019","journal-title":"Journal of Comparative Effectiveness Research"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521007114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521007114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:38:08Z","timestamp":1761543488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521007114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1542356521007114"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.06.047","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}